Human endogenous retrovirus-K (HML-2): a comprehensive review

References

• Aaronson SA, Todaro GJ, Scolnick EM. 1971. Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science. 174(4005):157–159.
   PubMed Web of Science ®Google Scholar
• Ade C, Roy-Engel AM, Deininger PL. 2013. Alu elements: an intrinsic source of human genome instability. Curr Opin Virol. 3(6):639–645.
   PubMed Web of Science ®Google Scholar
• Agoni L, Guha C, Lenz J. 2013. Detection of human endogenous retrovirus k (HERV-K) transcripts in human prostate cancer cell lines. Front Oncol. 3:180.
   PubMedGoogle Scholar
• Alfahad T, Nath A. 2013. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res. 99(2):180–187.
   PubMed Web of Science ®Google Scholar
• Andersson ML, Lindeskog M, Medstrand P, Westley B, May F, Blomberg J. 1999. Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol. 80(Pt 1):255–260.
   PubMedGoogle Scholar
• Andersson ML, Medstrand P, Yin H, Blomberg J. 1996. Differential expression of human endogenous retroviral sequences similar to mouse mammary tumor virus in normal peripheral blood mononuclear cells. AIDS Res Hum Retroviruses. 12(9):833–840.
   PubMed Web of Science ®Google Scholar
• Argaw-Denboba A, Balestrieri E, Serafino A, Cipriani C, Bucci I, Sorrentino R, Sciamanna I, Gambacurta A, Sinibaldi-Vallebona P, Matteucci C. 2017. HERV-K activation is strictly required to sustain CD133 + melanoma cells with stemness features. J Exp Clin Canc Res. 36:20.
   PubMed Web of Science ®Google Scholar
• Ariza ME, Williams MV. 2011. A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis? J Invest Dermatol. 131(12):2419–2427.
   PubMed Web of Science ®Google Scholar
• Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, Roemer K, Mueller-Lantzsch N. 2002. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin Cancer Res. 8(6):1800–1807.
   PubMed Web of Science ®Google Scholar
• Armbruester V, Sauter M, Roemer K, Best B, Hahn S, Nty A, Schmid A, Philipp S, Mueller A, Mueller-Lantzsch N. 2004. Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J Virol. 78(19):10310–10319.
   PubMed Web of Science ®Google Scholar
• Aydin H, Cook JD, Lee JE. 2014. Crystal structures of beta- and gammaretrovirus fusion proteins reveal a role for electrostatic stapling in viral entry. J Virol. 88(1):143–153.
   PubMed Web of Science ®Google Scholar
• Babaian A, Mager DL. 2016. Endogenous retroviral promoter exaptation in human cancer. Mob DNA. 7:24.
   PubMed Web of Science ®Google Scholar
• Bannert N, Kurth R. 2004. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A. 101(Suppl 2):14572–14579.
   PubMedGoogle Scholar
• Barazandeh M, Lambert SA, Albu M, Hughes TR. 2018. Comparison of ChIP-Seq data and a reference motif set for human KRAB C2H2 zinc finger proteins. G3 (Bethesda). 8(1):219–229.
   PubMedGoogle Scholar
• Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, Lenz J. 1999. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol. 9(16):861–868.
   PubMed Web of Science ®Google Scholar
• Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. 2003. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology. 308(1):1–12.
   PubMed Web of Science ®Google Scholar
• Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. 2005. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol. 79(19):12507–12514.
   PubMed Web of Science ®Google Scholar
• Bentvelzen P, Daams JH, Hageman P, Calafat J. 1970. Genetic transmission of viruses that incite mammary tumor in mice. Proc Natl Acad Sci U S A. 67(1):377.
   PubMed Web of Science ®Google Scholar
• Berkhout B, Jebbink M, Zsiros J. 1999. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol. 73(3):2365–2375.
   PubMed Web of Science ®Google Scholar
• Best S, Le Tissier PR, Stoye JP. 1997. Endogenous retroviruses and the evolution of resistance to retroviral infection. Trends Microbiol. 5(8):313–318.
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Maldarelli F, Mellors J, Coffin JM. 2014. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. J Virol. 88(19):11108–11120.
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Montesion M, Roy F, Coffin JM. 2015. Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1. Viruses. 7(3):939–968.
   PubMed Web of Science ®Google Scholar
• Bhat RK, Rudnick W, Antony JM, Maingat F, Ellestad KK, Wheatley BM, Tonjes RR, Power C. 2014. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS. PLoS One. 9(7):e97984.
   PubMed Web of Science ®Google Scholar
• Blaise S, de Parseval N, Benit L, Heidmann T. 2003. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci U S A. 100(22):13013–13018.
   PubMed Web of Science ®Google Scholar
• Blikstad V, Benachenhou F, Sperber GO, Blomberg J. 2008. Evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci. 65(21):3348–3365.
   PubMed Web of Science ®Google Scholar
• Blissenbach M, Grewe B, Hoffmann B, Brandt S, Uberla K. 2010. Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J Virol. 84(13):6598–6604.
   PubMed Web of Science ®Google Scholar
• Blomberg J, Benachenhou F, Blikstad V, Sperber G, Mayer J. 2009. Classification and nomenclature of endogenous retroviral sequences (ERVs): problems and recommendations. Gene. 448(2):115–123.
   PubMed Web of Science ®Google Scholar
• Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F, Cosset FL. 2000. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 74(7):3321–3329.
   PubMed Web of Science ®Google Scholar
• Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. 1997. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol. 71(6):4581–4588.
   PubMed Web of Science ®Google Scholar
• Boller K, Konig H, Sauter M, Muellerlantzsch N, Lower R, Lower J, Kurth R. 1993. Evidence that Herv-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus Htdv. Virology. 196(1):349–353.
   PubMed Web of Science ®Google Scholar
• Bowen LN, Tyagi R, Li W, Alfahad T, Smith B, Wright M, Singer EJ, Nath A. 2016. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 87(17):1756–1762.
   PubMed Web of Science ®Google Scholar
• Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD, Bushman FD. 2009. Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev. 23(5):633–642.
   PubMed Web of Science ®Google Scholar
• Bray S, Turnbull M, Hebert S, Douville RN. 2016. Insight into the ERVK integrase – propensity for DNA damage. Front Microbiol. 7:1941.
   PubMed Web of Science ®Google Scholar
• Brinzevich D, Young GR, Sebra R, Ayllon J, Maio SM, Deikus G, Chen BK, Fernandez-Sesma A, Simon V, Mulder LC. 2014. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. J Virol. 88(11):6213–6223.
   PubMed Web of Science ®Google Scholar
• Buscher K, Hahn S, Hofmann M, Trefzer U, Ozel M, Sterry W, Lower J, Lower R, Kurth R, Denner J. 2006. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 16(3):223–234.
   PubMed Web of Science ®Google Scholar
• Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. 2005. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 65(10):4172–4180.
   PubMed Web of Science ®Google Scholar
• Buzdin A, Kovalskaya-Alexandrova E, Gogvadze E, Sverdlov E. 2006. At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription. J Virol. 80(21):10752–10762.
   PubMed Web of Science ®Google Scholar
• Buzdin A, Ustyugova S, Khodosevich K, Mamedov I, Lebedev Y, Hunsmann G, Sverdlov E. 2003. Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages. Genomics. 81(2):149–156.
   PubMed Web of Science ®Google Scholar
• Cai BH, Chen JY, Lu MH, Chang LT, Lin HC, Chang YM, Chao CF. 2009. Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53. Nucleic Acids Res. 37(6):1984–1990.
   PubMed Web of Science ®Google Scholar
• Callahan R, Chiu IM, Wong JF, Tronick SR, Roe BA, Aaronson SA, Schlom J. 1985. A new class of endogenous human retroviral genomes. Science. 228(4704):1208–1211.
   PubMed Web of Science ®Google Scholar
• Cegolon L, Salata C, Weiderpass E, Vineis P, Palu G, Mastrangelo G. 2013. Human endogenous retroviruses and cancer prevention: evidence and prospects. BMC Cancer. 13:4.
   PubMed Web of Science ®Google Scholar
• Chaffanet M, Popovici C, Leroux D, Jacrot M, Adelaide J, Dastugue N, Gregoire MJ, Hagemeijer A, Lafage-Pochitaloff M, Birnbaum D et al. 1998. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene. 16(7):945–949.
   PubMed Web of Science ®Google Scholar
• Chen T, Meng Z, Gan Y, Wang X, Xu F, Gu Y, Xu X, Tang J, Zhou H, Zhang X et al. 2013. The viral oncogene Np9 acts as a critical molecular switch for co-activating beta-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia. 27(7):1469–-1478. English.
   PubMed Web of Science ®Google Scholar
• Cohen M, Larsson E. 1988. Human endogenous retroviruses. Bioessays. 9(6):191–196.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. 2007. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 23(9):1083–1086.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Contreras-Galindo A, Lorenzo E, Yamamura Y. 2006. Evidence for replication of human endogenous retroviruses type-K (HERV-K) in HIV-1 positive patients. Retrovirology. 3:S33.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Dube D, Fujinaga K, Kaplan MH, Markovitz DM. 2017. Susceptibility of human endogenous retrovirus type K to reverse transcriptase inhibitors. J Virol. 91(23):e01309-17.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y et al. 2012. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J Virol. 86(1):262–276.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Kaplan MH, Dube D, Gonzalez-Hernandez MJ, Chan S, Meng F, Dai M, Omenn GS, Gitlin SD, Markovitz DM. 2015. Human endogenous retrovirus type K (HERV-K) particles package and transmit HERV-K-related sequences. J Virol. 89(14):7187–7201.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. 2007. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. 23(1):116–122.
   PubMed Web of Science ®Google Scholar
• Costas J. 2001. Evolutionary dynamics of the human endogenous retrovirus family HERV-K inferred from full-length proviral genomes. J Mol Evol. 53(3):237–243.
   PubMed Web of Science ®Google Scholar
• de Parseval N, Lazar V, Casella JF, Benit L, Heidmann T. 2003. Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J Virol. 77(19):10414–10422.
   PubMed Web of Science ®Google Scholar
• Delelis O, Saib A, Sonigo P. 2003. Biphasic DNA synthesis in spumaviruses. J Virol. 77(14):8141–8146.
   PubMed Web of Science ®Google Scholar
• Denne M, Sauter M, Armbruester V, Licht JD, Roemer K, Mueller-Lantzsch N. 2007. Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J Virol. 81(11):5607–5616.
   PubMed Web of Science ®Google Scholar
• Denner J. 1998. Immunosuppression by retroviruses: implications for xenotransplantation. Ann N Y Acad Sci. 862:75–86.
   PubMed Web of Science ®Google Scholar
• Denner J. 2000. How does HIV induce AIDS? The virus protein hypothesis. J Human Virol. 3(2):81–82.
   PubMedGoogle Scholar
• Dewannieux M, Blaise S, Heidmann T. 2005. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol. 79(24):15573–15577.
   PubMed Web of Science ®Google Scholar
• Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16(12):1548–1556.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Rubalcaba E, Viscidi R, Yang S, Stallings C, Sullens A, Origoni A, Leister F, Yolken R. 2008. Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia. Schizophr Res. 104(1–3):121–126.
   PubMed Web of Science ®Google Scholar
• Diem O, Schaffner M, Seifarth W, Leib-Mosch C. 2012. Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells. PLoS One. 7(1):e30054.
   PubMed Web of Science ®Google Scholar
• Domansky AN, Kopantzev EP, Snezhkov EV, Lebedev YB, Leib-Mosch C, Sverdlov ED. 2000. Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region. FEBS Lett. 472(2–3):191–195.
   PubMed Web of Science ®Google Scholar
• Douville R, Liu J, Rothstein J, Nath A. 2011. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. 69(1):141–151.
   PubMed Web of Science ®Google Scholar
• Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM. 2014. Genomic flexibility of human endogenous retrovirus type K. J Virol. 88(17):9673–9682.
   PubMed Web of Science ®Google Scholar
• Dunn CA, Romanish MT, Gutierrez LE, van de Lagemaat LN, Mager DL. 2006. Transcription of two human genes from a bidirectional endogenous retrovirus promoter. Gene. 366(2):335–342.
   PubMed Web of Science ®Google Scholar
• Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD, Mehraein Y. 2006. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol. 33(1):16–23.
   PubMed Web of Science ®Google Scholar
• Esqueda D, Xu F, Moore Y, Yang Z, Huang G, Lennon PA, Hu PC, Dong J. 2013. Lack of correlation between HERV-K expression and HIV-1 viral load in plasma specimens. Ann Clin Lab Sci. 43(2):122–125.
   PubMed Web of Science ®Google Scholar
• Faulkner GJ, Carninci P. 2009. Altruistic functions for selfish DNA. Cell Cycle. 8(18):2895–2900.
   PubMed Web of Science ®Google Scholar
• Feuchter A, Mager D. 1990. Functional heterogeneity of a large family of human LTR-like promoters and enhancers. Nucleic Acids Res. 18(5):1261–1270.
   PubMed Web of Science ®Google Scholar
• Flockerzi A, Ruggieri A, Frank O, Sauter M, Maldener E, Kopper B, Wullich B, Seifarth W, Muller-Lantzsch N, Leib-Mosch C et al. 2008. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics. 9:354.
   PubMed Web of Science ®Google Scholar
• Fuchs NV, Kraft M, Tondera C, Hanschmann KM, Lower J, Lower R. 2011. Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J Virol. 85(7):3436–3448.
   PubMed Web of Science ®Google Scholar
• Fuchs NV, Loewer S, Daley GQ, Izsvak Z, Lower J, Lower R. 2013. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells. Retrovirology. 10:115.
   PubMed Web of Science ®Google Scholar
• Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM et al. 2007. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog. 3(11):e165.
   PubMed Web of Science ®Google Scholar
• Gautam P, Yu T, Loh YH. 2017. Regulation of ERVs in pluripotent stem cells and reprogramming. Curr Opin Genet Dev. 46:194–201.
   PubMed Web of Science ®Google Scholar
• George M, Schwecke T, Beimforde N, Hohn O, Chudak C, Zimmermann A, Kurth R, Naumann D, Bannert N. 2011. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element. Retrovirology. 8:30.
   PubMed Web of Science ®Google Scholar
• Gogvadze E, Stukacheva E, Buzdin A, Sverdlov E. 2009. Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions. J Virol. 83(12):6098–6105.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cao M, Iduma P, Karachaliou N, Santarpia M, Blanco J, Rosell R. 2016. Human endogenous retroviruses and cancer. Cancer Biol Med. 13(4):483–488.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ, Kaplan MH, Markovitz DM. 2012. Expression of human endogenous retrovirus type K (HML-2) is activated by the TAT protein of HIV-1. J Virol. 86(15):7790–7805.
   PubMed Web of Science ®Google Scholar
• Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, Martin L, Ware CB, Blish CA, Chang HY et al. 2015. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature. 522(7555):221–225.
   PubMed Web of Science ®Google Scholar
• Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, Pebusque MJ. 2003. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood. 101(1):286–288.
   PubMed Web of Science ®Google Scholar
• Hanke K, Chudak C, Kurth R, Bannert N. 2013. The Rec protein of HERV-K(HML-2) upregulates androgen receptor activity by binding to the human small glutamine-rich tetratricopeptide repeat protein (hSGT). Int J Cancer. 132(3):556–567.
   PubMed Web of Science ®Google Scholar
• Hanke K, Hohn O, Liedgens L, Fiddeke K, Wamara J, Kurth R, Bannert N. 2013. Staufen-1 interacts with the human endogenous retrovirus family HERV-K(HML-2) rec and gag proteins and increases virion production. J Virol. 87(20):11019–11030.
   PubMed Web of Science ®Google Scholar
• Hanke K, Kramer P, Seeher S, Beimforde N, Kurth R, Bannert N. 2009. Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain. J Virol. 83(24):12790–12800.
   PubMed Web of Science ®Google Scholar
• Harris JM, Haynes RH, McIntosh EM. 1997. A consensus sequence for a functional human endogenous retrovirus K (HERV-K) dUTPase. Biochem Cell Biol. 75(2):143–151.
   PubMed Web of Science ®Google Scholar
• Henzy JE, Coffin JM. 2013. Betaretroviral envelope subunits are noncovalently associated and restricted to the mammalian class. J Virol. 87(4):1937–1946.
   PubMed Web of Science ®Google Scholar
• Herbst H, Sauter M, Mueller-Lantzsch N. 1996. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol. 149(5):1727–1735.
   PubMed Web of Science ®Google Scholar
• Hohn O, Hanke K, Bannert N. 2013. HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front Oncol. 3:246.
   PubMedGoogle Scholar
• Holt MP, Shevach EM, Punkosdy GA. 2013. Endogenous mouse mammary tumor viruses (mtv): new roles for an old virus in cancer, infection, and immunity. Front Oncol. 3:287.
   PubMedGoogle Scholar
• Hughes JF, Coffin JM. 2001. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet. 29(4):487–489.
   PubMed Web of Science ®Google Scholar
• Hughes JF, Coffin JM. 2004. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci U S A. 101(6):1668–1672.
   PubMed Web of Science ®Google Scholar
• Huh JW, Kim DS, Kang DW, Ha HS, Ahn K, Noh YN, Min DS, Chang KT, Kim HS. 2008. Transcriptional regulation of GSDML gene by antisense-oriented HERV-H LTR element. Arch Virol. 153(6):1201–1205.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Odaka T. 1984. A cell membrane "gp70" associated with Fv-4 gene: immunological characterization, and tissue and strain distribution. Virology. 133(1):65–76.
   PubMed Web of Science ®Google Scholar
• Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y et al. 2008. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun. 8:15.
   PubMedGoogle Scholar
• Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF et al. 2012. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Invest. 122(12):4473–4489.
   PubMed Web of Science ®Google Scholar
• Kammerer U, Germeyer A, Stengel S, Kapp M, Denner J. 2011. Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta. J Reprod Immunol. 91(1–2):1–8. English.
   PubMed Web of Science ®Google Scholar
• Kapitonov VV, Jurka J. 1999. The long terminal repeat of an endogenous retrovirus induces alternative splicing and encodes an additional carboxy-terminal sequence in the human leptin receptor. J Mol Evol. 48(2):248–251.
   PubMed Web of Science ®Google Scholar
• Karamitros T, Paraskevis D, Hatzakis A, Psichogiou M, Elefsiniotis I, Hurst T, Geretti AM, Beloukas A, Frater J, Klenerman P et al. 2016. A contaminant-free assessment of Endogenous Retroviral RNA in human plasma. Sci Rep. 6:33598.
   PubMed Web of Science ®Google Scholar
• Katoh I, Mirova A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, Sakai T, Hashimoto K, Maruyama A, Yonaga T et al. 2011. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M. Neoplasia. 13(11):1081–1092.
   PubMed Web of Science ®Google Scholar
• Kempf L, Nicodemus KK, Kolachana B, Vakkalanka R, Verchinski BA, Egan MF, Straub RE, Mattay VA, Callicott JH, Weinberger DR et al. 2008. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet. 4(11):e1000252.
   PubMed Web of Science ®Google Scholar
• Khodosevich K, Lebedev Y, Sverdlov ED. 2004. Large-scale determination of the methylation status of retrotransposons in different tissues using a methylation tags approach. Nucleic Acids Res. 32(3):e31.
   PubMed Web of Science ®Google Scholar
• Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, Hansen N, Teague B, Alkan C, Antonacci F et al. 2008. Mapping and sequencing of structural variation from eight human genomes. Nature. 453(7191):56–64.
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Ayukawa T, Ishikawa T, Kanda T, Yoshiike K. 1996. Human endogenous retrovirus K10 encodes a functional integrase. J Virol. 70(5):3302–3306.
   PubMed Web of Science ®Google Scholar
• Knossl M, Lower R, Lower J. 1999. Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1. J Virol. 73(2):1254–1261.
   PubMed Web of Science ®Google Scholar
• Koppe B, Menendez-Arias L, Oroszlan S. 1994. Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. J Virol. 68(4):2313–2319.
   PubMed Web of Science ®Google Scholar
• Kovalskaya E, Buzdin A, Gogvadze E, Vinogradova T, Sverdlov E. 2006. Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions. Virology. 346(2):373–378.
   PubMed Web of Science ®Google Scholar
• Kramer P, Lausch V, Volkwein A, Hanke K, Hohn O, Bannert N. 2016. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step. Virology. 487:121–128.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Rabinovich BA, Mi T, Switzer KC, Olivares S, Maiti SN, Plummer JB, Singh H, Kumaresan PR, Huls HM et al. 2015. Genetic engineering of T cells to target HERV-K, an ancient retrovirus on melanoma. Clin Cancer Res. 21(14):3241–3251.
   PubMed Web of Science ®Google Scholar
• Krzysztalowska-Wawrzyniak M, Ostanek M, Clark J, Binczak-Kuleta A, Ostanek L, Kaczmarczyk M, Loniewska B, Wyrwicz LS, Brzosko M, Ciechanowicz A. 2011. The distribution of human endogenous retrovirus K-113 in health and autoimmune diseases in Poland. Rheumatology (Oxford). 50(7):1310–1314.
   PubMed Web of Science ®Google Scholar
• Kurth R, Bannert N. 2010. Beneficial and detrimental effects of human endogenous retroviruses. Int J Cancer. 126(2):306–314.
   PubMed Web of Science ®Google Scholar
• Laderoute MP, Giulivi A, Larocque L, Bellfoy D, Hou Y, Wu HX, Fowke K, Wu J, Diaz-Mitoma F. 2007. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. AIDS. 21(18):2417–2424.
   PubMed Web of Science ®Google Scholar
• Laderoute MP, Larocque LJ, Giulivi A, Diaz-Mitoma F. 2015. Further evidence that human endogenous retrovirus K102 is a replication competent foamy virus that may antagonize HIV-1 replication. Open AIDS J. 9:112–122.
   PubMedGoogle Scholar
• Langner JS, Fuchs NV, Hoffmann J, Wittmann A, Brutschy B, Lower R, Suess B. 2012. Biochemical analysis of the complex between the tetrameric export adapter protein Rec of HERV-K/HML-2 and the responsive RNA element RcRE pck30. J Virol. 86(17):9079–9087.
   PubMed Web of Science ®Google Scholar
• Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ, 3rd, Lohr JG, Harris CC, Ding L, Wilson RK et al. 2012. Landscape of somatic retrotransposition in human cancers. Science. 337(6097):967–971.
   PubMed Web of Science ®Google Scholar
• Lee YN, Bieniasz PD. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3(1):e10.
   PubMed Web of Science ®Google Scholar
• Lemaitre C, Harper F, Pierron G, Heidmann T, Dewannieux M. 2014. The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity. J Virol. 88(23):13626–13637.
   PubMed Web of Science ®Google Scholar
• Lemaitre C, Tsang J, Bireau C, Heidmann T, Dewannieux M. 2017. A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion. PLoS Pathog. 13(6):e1006451.
   PubMed Web of Science ®Google Scholar
• Li M, Radvanyi LG, Yin B, Li J, Chivukula R, Lin K, Lu Y, Shen J, Chang DZ, Li D et al. 2017. Down-regulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clin Cancer Res. 23:5892–5911.
   PubMed Web of Science ®Google Scholar
• Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K et al. 2015. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 7(307):307ra153.
   PubMed Web of Science ®Google Scholar
• Li XJ, Hanson C, Cmarik JL, Ruscetti S. 2009. Neurodegeneration induced by PVC-211 murine leukemia virus is associated with increased levels of vascular endothelial growth factor and macrophage inflammatory protein 1 alpha and is inhibited by blocking activation of microglia. J Virol. 83(10):4912–4922.
   PubMed Web of Science ®Google Scholar
• Liang X, Fu C, Cui W, Ober-Blobaum JL, Zahner SP, Shrikant PA, Clausen BE, Flavell RA, Mellman I, Jiang A. 2014. Beta-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8(+) T cells. J Leukoc Biol. 95(1):179–190.
   PubMed Web of Science ®Google Scholar
• Linial ML. 1999. Foamy viruses are unconventional retroviruses. J Virol. 73(3):1747–1755.
   PubMed Web of Science ®Google Scholar
• Longo MC, Berninger MS, Hartley JL. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain-reactions. Gene. 93(1):125–128.
   PubMed Web of Science ®Google Scholar
• Lori F, Veronese FD, Devico AL, Lusso P, Reitz MS, Gallo RC. 1992. Viral-DNA carried by human-immunodeficiency-virus type-1 virions. J Virol. 66(8):5067–5074.
   PubMed Web of Science ®Google Scholar
• Lower R, Lower J, Frank H, Harzmann R, Kurth R. 1984. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol. 65(Pt 5):887–898.
   PubMedGoogle Scholar
• Lower R, Lower J, Tondera-Koch C, Kurth R. 1993. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology. 192(2):501–511.
   PubMed Web of Science ®Google Scholar
• Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. 1995. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol. 69(1):141–149.
   PubMed Web of Science ®Google Scholar
• Macfarlane C, Simmonds P. 2004. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J Mol Evol. 59(5):642–656.
   PubMed Web of Science ®Google Scholar
• Magin C, Lower R, Lower J. 1999. cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol. 73(11):9496–9507.
   PubMed Web of Science ®Google Scholar
• Magin-Lachmann C, Hahn S, Strobel H, Held U, Lower J, Lower R. 2001. Rec (formerly corf) function requires interaction with a complex, folded RNA structure within its responsive element rather than binding to a discrete specific binding site. J Virol. 75(21):10359–10371.
   PubMed Web of Science ®Google Scholar
• Manghera M, Douville RN. 2013. Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology. 10:16.
   PubMed Web of Science ®Google Scholar
• Manghera M, Ferguson J, Douville R. 2015. ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease. Viruses. 7(1):320–332.
   PubMed Web of Science ®Google Scholar
• Manghera M, Ferguson-Parry J, Lin R, Douville RN. 2016. NF-kappaB and IRF1 induce endogenous retrovirus k expression via interferon-stimulated response elements in its 5' long terminal repeat. J Virol. 90(20):9338–9349.
   PubMed Web of Science ®Google Scholar
• Marchi E, Kanapin A, Magiorkinis G, Belshaw R. 2014. Unfixed endogenous retroviral insertions in the human population. J Virol. 88(17):9529–9537.
   PubMed Web of Science ®Google Scholar
• Marguerat S, Wang WY, Todd JA, Conrad B. 2004. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes. 53(3):852–854.
   PubMed Web of Science ®Google Scholar
• Martin MA, Bryan T, Rasheed S, Khan AS. 1981. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A. 78(8):4892–4896.
   PubMed Web of Science ®Google Scholar
• Mayer J, Ehlhardt S, Seifert M, Sauter M, Muller-Lantzsch N, Mehraein Y, Zang KD, Meese E. 2004. Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology. 322(1):190–198.
   PubMed Web of Science ®Google Scholar
• Mayer J, Meese EU. 2003. Presence of dUTPase in the various human endogenous retrovirus K (HERV-K) families. J Mol Evol. 57(6):642–649.
   PubMed Web of Science ®Google Scholar
• Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. 1999. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet. 21(3):257–258.
   PubMed Web of Science ®Google Scholar
• McClintock B. 1950. The origin and behavior of mutable loci in maize. Proc Natl Acad Sci U S A. 36(6):344–355.
   PubMed Web of Science ®Google Scholar
• McCormick AL, Brown RH, Jr., Cudkowicz ME, Al-Chalabi A, Garson JA. 2008. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 70(4):278–283.
   PubMed Web of Science ®Google Scholar
• McIntosh EM, Haynes RH. 1996. HIV and human endogenous retroviruses: an hypothesis with therapeutic implications. Acta Biochim Pol. 43(4):583–592.
   PubMed Web of Science ®Google Scholar
• Medstrand P, Blomberg J. 1993. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol. 67(11):6778–6787.
   PubMed Web of Science ®Google Scholar
• Medstrand P, Mager DL. 1998. Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol. 72(12):9782–9787.
   PubMed Web of Science ®Google Scholar
• Medstrand P, Mager DL, Yin H, Dietrich U, Blomberg J. 1997. Structure and genomic organization of a novel human endogenous retrovirus family: HERV-K (HML-6). J Gen Virol. 78(Pt 7):1731–1744.
   PubMedGoogle Scholar
• Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF. 2014. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology. 11:10.
   PubMed Web of Science ®Google Scholar
• Moelling K, Broecker F. 2015. The reverse transcriptase-RNase H: from viruses to antiviral defense. Ann N Y Acad Sci. 1341:126–135.
   PubMed Web of Science ®Google Scholar
• Monde K, Contreras-Galindo R, Kaplan MH, Markovitz DM, Ono A. 2012. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. J Virol. 86(20):11194–11208.
   PubMed Web of Science ®Google Scholar
• Monde K, Terasawa H, Nakano Y, Soheilian F, Nagashima K, Maeda Y, Ono A. 2017. Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity. Retrovirology. 14(1):27.
   PubMedGoogle Scholar
• Morozov VA, Dao Thi VL, Denner J. 2013. The transmembrane protein of the human endogenous retrovirus–K (HERV-K) modulates cytokine release and gene expression. PLoS One. 8(8):e70399.
   PubMed Web of Science ®Google Scholar
• Moyes D, Griffiths DJ, Venables PJ. 2007. Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet. 23(7):326–333.
   PubMed Web of Science ®Google Scholar
• Mueller-Lantzsch N, Sauter M, Weiskircher A, Kramer K, Best B, Buck M, Grasser F. 1993. Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. AIDS Res Hum Retroviruses. 9(4):343–350.
   PubMed Web of Science ®Google Scholar
• Muradrasoli S, Forsman A, Hu L, Blikstad V, Blomberg J. 2006. Development of real-time PCRs for detection and quantitation of human MMTV-like (HML) sequences HML expression in human tissues. J Virol Methods. 136(1–2):83–92.
   PubMed Web of Science ®Google Scholar
• Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, Fodinger D, Seppele H, Schanab O, Magin-Lachmann C et al. 2003. An endogenous retrovirus derived from human melanoma cells. Cancer Res. 63(24):8735–8741.
   PubMed Web of Science ®Google Scholar
• Ono M. 1986. Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol. 58(3):937–944.
   PubMed Web of Science ®Google Scholar
• Ono M, Yasunaga T, Miyata T, Ushikubo H. 1986. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol. 60(2):589–598.
   PubMed Web of Science ®Google Scholar
• Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C. 2007. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 26(29):4226–4233.
   PubMed Web of Science ®Google Scholar
• Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vazquez-Perez JA, Reyes-Teran G et al. 2012. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection. PLoS One. 7(8):e41021.
   PubMed Web of Science ®Google Scholar
• Otowa T, Tochigi M, Rogers M, Umekage T, Kato N, Sasaki T. 2006. Insertional polymorphism of endogenous retrovirus HERV-K115 in schizophrenia. Neurosci Lett. 408(3):226–229.
   PubMed Web of Science ®Google Scholar
• Pani MA, Wood JP, Bieda K, Toenjes RR, Usadel KH, Badenhoop K. 2002. The variable endogenous retroviral insertion in the human complement C4 gene: a transmission study in type I diabetes mellitus. Hum Immunol. 63(6):481–484.
   PubMed Web of Science ®Google Scholar
• Perot P, Mugnier N, Montgiraud C, Gimenez J, Jaillard M, Bonnaud B, Mallet F. 2012. Microarray-based sketches of the HERV transcriptome landscape. PLoS One. 7(6):e40194.
   PubMed Web of Science ®Google Scholar
• Ponferrada VG, Mauck BS, Wooley DP. 2003. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus. Arch Virol. 148(4):659–675.
   PubMed Web of Science ®Google Scholar
• Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H et al. 2013. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res. 19(22):6112–6125.
   PubMed Web of Science ®Google Scholar
• Rethwilm A. 2003. The replication strategy of foamy viruses. Curr Top Microbiol Immunol. 277:1–26.
   PubMed Web of Science ®Google Scholar
• Reus K, Mayer J, Sauter M, Scherer D, Muller-Lantzsch N, Meese E. 2001. Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7. Genomics. 72(3):314–320.
   PubMed Web of Science ®Google Scholar
• Reus K, Mayer J, Sauter M, Zischler H, Muller-Lantzsch N, Meese E. 2001. HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2). J Virol. 75(19):8917–8926.
   PubMed Web of Science ®Google Scholar
• Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G et al. 2015. Integrative clinical genomics of advanced prostate cancer. Cell. 161(5):1215–1228.
   PubMed Web of Science ®Google Scholar
• Robinson LR, Whelan SP. 2016. Infectious entry pathway mediated by the human endogenous retrovirus K envelope protein. J Virol. 90(7):3640–3649.
   PubMed Web of Science ®Google Scholar
• Romano CM, Ramalho RF, Zanotto PM. 2006. Tempo and mode of ERV-K evolution in human and chimpanzee genomes. Arch Virol. 151(11):2215–2228.
   PubMed Web of Science ®Google Scholar
• Ruggieri A, Maldener E, Sauter M, Mueller-Lantzsch N, Meese E, Fackler OT, Mayer J. 2009. Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec. Retrovirology. 6:17.
   PubMed Web of Science ®Google Scholar
• Schmitt K, Heyne K, Roemer K, Meese E, Mayer J. 2015. HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues. Mobile DNA-Uk. 6:4.
   PubMed Web of Science ®Google Scholar
• Schmitt K, Reichrath J, Roesch A, Meese E, Mayer J. 2013. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol. 5(2):307–328.
   PubMed Web of Science ®Google Scholar
• Schommer S, Sauter M, Krausslich HG, Best B, Mueller-Lantzsch N. 1996. Characterization of the human endogenous retrovirus K proteinase. J Gen Virol. 77(Pt 2):375–379.
   PubMedGoogle Scholar
• Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. 1996. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci U S A. 93(25):14759–14764.
   PubMed Web of Science ®Google Scholar
• Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, Leib-Mosch C. 2005. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol. 79(1):341–352.
   PubMed Web of Science ®Google Scholar
• SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN et al. 2011. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J Virol. 85(14):6977–6985.
   PubMed Web of Science ®Google Scholar
• Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RH, Jr., Garson JA. 2005. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 64(3):454–458.
   PubMed Web of Science ®Google Scholar
• Subramanian RP, Wildschutte JH, Russo C, Coffin JM. 2011. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 8:90.
   PubMed Web of Science ®Google Scholar
• Sugimoto J, Matsuura N, Kinjo Y, Takasu N, Oda T, Jinno Y. 2001. Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. Genomics. 72(2):137–144.
   PubMed Web of Science ®Google Scholar
• Suntsova M, Gogvadze EV, Salozhin S, Gaifullin N, Eroshkin F, Dmitriev SE, Martynova N, Kulikov K, Malakhova G, Tukhbatova G et al. 2013. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. P Natl Acad Sci U S A. 110(48):19472–19477.
   PubMed Web of Science ®Google Scholar
• Suryawanshi A, Manicassamy S. 2015. Tumors induce immune tolerance through activation of beta-catenin/TCF4 signaling in dendritic cells: a novel therapeutic target for cancer immunotherapy. Oncoimmunology. 4(12):e1052932.
   PubMed Web of Science ®Google Scholar
• Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA et al. 2011. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. J Virol. 85(21):11526–11531.
   PubMed Web of Science ®Google Scholar
• Terry SN, Manganaro L, Cuesta-Dominguez A, Brinzevich D, Simon V, Mulder LCF. 2017. Expression of HERV-K108 envelope interferes with HIV-1 production. Virology. 509:52–59.
   PubMed Web of Science ®Google Scholar
• Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B et al. 2007. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 448(7153):595–599.
   PubMed Web of Science ®Google Scholar
• Tonjes RR, Czauderna F, Kurth R. 1999. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol. 73(11):9187–9195.
   PubMed Web of Science ®Google Scholar
• Trono D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol. 66(8):4893–4900.
   PubMed Web of Science ®Google Scholar
• Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol. 11(19):1531–1535.
   PubMed Web of Science ®Google Scholar
• Tyagi R, Li W, Parades D, Bianchet MA, Nath A. 2017. Inhibition of human endogenous retrovirus-K by antiretroviral drugs. Retrovirology. 14(1):21.
   PubMedGoogle Scholar
• van der Kuyl AC. 2012. HIV infection and HERV expression: a review. Retrovirology. 9:6.
   PubMed Web of Science ®Google Scholar
• Vertessy BG, Toth J. 2009. Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases. Acc Chem Res. 42(1):97–106.
   PubMed Web of Science ®Google Scholar
• Vincendeau M, Gottesdorfer I, Schreml JM, Wetie AG, Mayer J, Greenwood AD, Helfer M, Kramer S, Seifarth W, Hadian K et al. 2015. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Retrovirology. 12:27.
   PubMed Web of Science ®Google Scholar
• Viola MV, Frazier M, White L, Brody J, Spiegelman S. 1975. RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients. J Exp Med. 142(2):483–494.
   PubMed Web of Science ®Google Scholar
• Vogetseder W, Dumfahrt A, Mayersbach P, Schonitzer D, Dierich MP. 1993. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. AIDS Res Hum Retroviruses. 9(7):687–694.
   PubMed Web of Science ®Google Scholar
• Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D. 2007. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci U S A. 104(47):18613–18618.
   PubMed Web of Science ®Google Scholar
• Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL. 2007. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer. 120(1):81–90.
   PubMed Web of Science ®Google Scholar
• Watanabe T. 2017. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood. 129(9):1071–1081.
   PubMed Web of Science ®Google Scholar
• Weiss RA. 1969a. The host range of Bryan strain Rous sarcoma virus synthesized in the absence of helper virus. J Gen Virol. 5:511–528.
   Web of Science ®Google Scholar
• Weiss RA. 1969b. Interference and neutralization studies with Bryan strain Rous sarcoma virus synthesized in the absence of helper virus. J Gen Virol. 5:529–539.
   Web of Science ®Google Scholar
• Weiss RA. 2006. The discovery of endogenous retroviruses. Retrovirology. 3:67.
   PubMed Web of Science ®Google Scholar
• Whitelaw E, Martin DIK. 2001. Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet. 27(4):361–365.
   PubMed Web of Science ®Google Scholar
• Wildschutte JH, Ram D, Subramanian R, Stevens VL, Coffin JM. 2014. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls. Retrovirology. 11:62.
   PubMed Web of Science ®Google Scholar
• Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM. 2016. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci U S A. 113(16):E2326–E2334.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Mager D, Leong JC. 1994. Endogenous human retroviruses. In: Levy J, editor. The retroviridae. New York: Plenum Press; p. 465–535.
   Google Scholar
• Wodrich H, Krausslich HG. 2001. Nucleocytoplasmic RNA transport in retroviral replication. Results Probl Cell Differ. 34:197–217.
   PubMedGoogle Scholar
• Wolf G, Yang P, Fuchtbauer AC, Fuichtbauer EM, Silva AM, Park C, Wu WR, Nielsen AL, Pedersen FS, Macfarlan TS. 2015. The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses. Gene Dev. 29(5):538–554.
   PubMed Web of Science ®Google Scholar
• Yang BX, El Farran CA, Guo HC, Yu T, Fang HT, Wang HF, Schlesinger S, Seah YF, Goh GY, Neo SP et al. 2015. Systematic identification of factors for provirus silencing in embryonic stem cells. Cell. 163(1):230–245.
   PubMed Web of Science ®Google Scholar
• Yin H, Medstrand P, Kristofferson A, Dietrich U, Aman P, Blomberg J. 1999. Characterization of human MMTV-like (HML) elements similar to a sequence that was highly expressed in a human breast cancer: further definition of the HML-6 group. Virology. 256(1):22–35.
   PubMed Web of Science ®Google Scholar
• Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. 1996. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science. 271(5255):1579–1582.
   PubMed Web of Science ®Google Scholar
• Yu SF, Sullivan MD, Linial ML. 1999. Evidence that the human foamy virus genome is DNA. J Virol. 73(2):1565–1572.
   PubMed Web of Science ®Google Scholar
• Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning F. 2015. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology. 4(11):e1047582.
   PubMed Web of Science ®Google Scholar